Safety profile of autologous macrophage therapy for liver cirrhosis
| dc.contributor.author | Moroni, Francesca | |
| dc.contributor.author | Dwyer, Benjamin J | |
| dc.contributor.author | Graham, Catriona | |
| dc.contributor.author | Pass, Chloe | |
| dc.contributor.author | Bailey, Laura | |
| dc.contributor.author | Ritchie, Lisa | |
| dc.contributor.author | Mitchell, Donna | |
| dc.contributor.author | Glover, Alison | |
| dc.contributor.author | Laurie, Audrey | |
| dc.contributor.author | Doig, Stuart | |
| dc.contributor.author | Hargreaves, Emily | |
| dc.contributor.author | Fraser, Alasdair R | |
| dc.contributor.author | Turner, Marc L | |
| dc.contributor.author | Campbell, John D M | |
| dc.contributor.author | McGowan, Neil W A | |
| dc.contributor.author | Barry, Jacqueline | |
| dc.contributor.author | Moore, Joanna K | |
| dc.contributor.author | Hayes, Peter C | |
| dc.contributor.author | Leeming, Diana J | |
| dc.contributor.author | Nielsen, Mette J | |
| dc.contributor.author | Musa, Kishwar | |
| dc.contributor.author | Fallowfield, Jonathan A | |
| dc.contributor.author | Forbes, Stuart J | |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.date.accessioned | 2020-04-06T23:53:17Z | |
| dc.date.available | 2020-04-06T23:53:17Z | |
| dc.date.embargoedUntil | 2020-04-07 | |
| dc.date.issued | 2019-10 | |
| dc.description | This work was supported by a Medical Research Council UK grant (Biomedical Catalyst Major Awards Committee; reference MR/M007588/1) to S.J. Forbes. We thank Z.M. Younossi (Center for Outcomes Research in Liver Diseases, Washington, DC, USA) for academic use of the CLDQ instrument and L.J. Fallowfield (Sussex Health Outcomes Research & Education in Cancer (SHORE-C), University of Sussex, UK) for advice about health-related quality of life assessment. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 6 | |
| dc.format.extent | 839879 | |
| dc.format.extent | 176416 | |
| dc.format.extent | 112433 | |
| dc.format.extent | 185766 | |
| dc.identifier | 148412768 | |
| dc.identifier | 297a270f-2120-4637-a85d-713fe132d2ff | |
| dc.identifier | 31591593 | |
| dc.identifier | 000489166700025 | |
| dc.identifier | 85074194479 | |
| dc.identifier.citation | Moroni, F, Dwyer, B J, Graham, C, Pass, C, Bailey, L, Ritchie, L, Mitchell, D, Glover, A, Laurie, A, Doig, S, Hargreaves, E, Fraser, A R, Turner, M L, Campbell, J D M, McGowan, N W A, Barry, J, Moore, J K, Hayes, P C, Leeming, D J, Nielsen, M J, Musa, K, Fallowfield, J A & Forbes, S J 2019, 'Safety profile of autologous macrophage therapy for liver cirrhosis', Nature Medicine, vol. 25, pp. 1560-1565. https://doi.org/10.1038/s41591-019-0599-8 | en |
| dc.identifier.doi | 10.1038/s41591-019-0599-8 | |
| dc.identifier.issn | 1078-8956 | |
| dc.identifier.uri | https://hdl.handle.net/2164/13978 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85074194479&partnerID=8YFLogxK | en |
| dc.identifier.vol | 25 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Nature Medicine | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | regeneration | en |
| dc.subject | translational research | en |
| dc.subject | DIAGNOSIS | en |
| dc.subject | MARKER | en |
| dc.subject | DISEASE | en |
| dc.subject | INJURY | en |
| dc.subject | FUNCTIONAL-CHARACTERIZATION | en |
| dc.subject | CELL THERAPY | en |
| dc.subject | DUCTULAR REACTIONS | en |
| dc.subject | TRANSPLANTATION | en |
| dc.subject | R Medicine | en |
| dc.subject | General Biochemistry,Genetics and Molecular Biology | en |
| dc.subject | Medical Research Council (MRC) | en |
| dc.subject | MR/M007588/1 | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | Safety profile of autologous macrophage therapy for liver cirrhosis | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 4 of 4
- Name:
- Moroni_et_al_NM_safety_profile_autologous_AAM.pdf
- Size:
- 820.19 KB
- Format:
- Adobe Portable Document Format
